Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18983569 | 0.81 | KDM4E (0.67) | ALDH1A1KDM4ELMNAKMT2AMEN1 | |
| SCHEMBL11117971 | 0.77 | ALDH1A1 (0.46) | ALDH1A1KDM4ELMNAKMT2AMEN1 | |
| SCHEMBL4766358 | 0.73 | GAA (0.69) | ALDH1A1KDM4ELMNAKMT2AMEN1 | |
| SCHEMBL483417 | 0.73 | GAA (0.46) | ALDH1A1KDM4ELMNAKMT2AMEN1 | |
| SCHEMBL28559053 | 0.71 | HPGD (0.50) | LMNAKMT2AMEN1CYP1A2CYP3A4 | |
| SCHEMBL29519193 | 0.71 | SMN1; SMN2 (0.54) | ALDH1A1KDM4ELMNAKMT2AMEN1 | |
| SCHEMBL1226530 | 0.71 | SMN1; SMN2 (0.54) | ALDH1A1KDM4ELMNAKMT2AMEN1 | |
| SCHEMBL672473 | 0.70 | RAB9A (0.48) | ALDH1A1KDM4ELMNAKMT2AMEN1 | |
| SCHEMBL4691712 | 0.69 | ALDH1A1 (0.46) | ALDH1A1LMNAKMT2AMEN1CYP1A2 | |
| SCHEMBL16213446 | 0.69 | KDM4E (0.65) | ALDH1A1KDM4ELMNAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240953-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2023-08-03 | — | — | US | claimed |
| EP-4171531-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2023-05-03 | — | — | EP | claimed |
| CN-107613767-B | Synergistic preservative composition | ISP投资有限公司 | 2022-06-21 | — | — | CN | claimed |
| US-20220030862-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-02-03 | — | — | US | claimed |
| US-11224222-B2 | Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions | ISP INVESTMENTS LLC (US) | 2022-01-18 | — | — | US | claimed |
| WO-2022005930-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-01-06 | — | — | WO | claimed |
| EP-3886582-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2021-10-06 | — | — | EP | claimed |
| WO-2020113211-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2020-06-04 | — | — | WO | claimed |
| EP-3280449-B1 | AN AQUEOUS MULTILAMELLAR COMPOSITION FOR DELIVERING HYDROPHOBIC SUBSTANCES | ISP INVESTMENTS LLC (US) | 2019-11-20 | — | — | EP | claimed |
| US-20180092843-A1 | AN AQUEOUS MULTILAMELLAR COMPOSITION FOR DELIVERING HYDROPHOBIC SUBSTANCES | ISP INVESTMENTS LLC (US) | 2018-04-05 | — | — | US | claimed |
| US-20130195947-A1 | BIOCIDE POWDER FORMULATION | TROY TECHNOLOGY II, INC. | 2013-08-01 | — | — | US | claimed |
| EP-2547208-A1 | BIOCIDE POWDER FORMULATION | Isp Investments Inc. (US) | 2013-01-23 | — | — | EP | claimed |
| EP-2538781-A2 | PROCESS FOR THE CO-ENCAPSULATION OF BIOCIDALLY ACTIVE COMPOUNDS IN CLAY MINERALS FUNCTIONALIZED BY NITROGEN COMPOUNDS | Clariant S.A., Brazil (BR) | 2013-01-02 | — | — | EP | claimed |
| US-20120316259-A1 | Process For The Co-Encapsulation Of Biocidally Active Compounds In Clay Minerals Functionalized By Nitrogen Compounds | CLARIANT S.A. BRAZIL (BR) | 2012-12-13 | — | — | US | claimed |
| WO-2012024097-A1 | THERMO-STABLE, ARSENIC-FREE SYNERGISTIC BIOCIDE CONCENTRATE COMPOSITION FOR POLYMER MATRICES AND PROCESS FOR PREPARING SAME | ISP INVESTMENTS INC. (US) | 2012-02-23 | — | — | WO | claimed |
| WO-2011116168-A1 | BIOCIDE POWER FORMULATION | ISP INVESTMENTS INC. (US) | 2011-09-22 | — | — | WO | claimed |
| WO-2011103969-A2 | PROCESS FOR THE CO-ENCAPSULATION OF BIOCIDALLY ACTIVE COMPOUNDS IN CLAY MINERALS FUNCTIONALIZED BY NITROGEN COMPOUNDS | CLARIANT S. A. BRAZIL (BR) | 2011-09-01 | — | — | WO | claimed |
| US-7951852-B2 | Mixing a microbiocide such as iodopropynyl butyl carbamate with a dry lubricant such as calcium stearate or zinc stearate to form a free-flowing powder additive for polymer, plastic, or polymer-wood composites | ISP INVESTMENTS INC. (US) | 2011-05-31 | — | — | US | claimed |
| US-20060229381-A1 | Free-flowing composition of a biocide and a processing additive therewith for incorporation into a polymer or plastic matrix product | ISP INVESTMENTS INC. | 2006-10-12 | — | — | US | claimed |
| US-20060013847-A1 | Thermal stabilization of IPBC biocide | ISP INVESTMENTS INC. | 2006-01-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180092843-A1 | AN AQUEOUS MULTILAMELLAR COMPOSITION FOR DELIVERING HYDROPHOBIC SUBSTANCES | LIPA, PHOSPHO1, DAGLA | ALDH1A1 1611/4885KDM4E 2953/4885LMNA 1395/4885 |
| US-20230240953-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | MPO, SPOUT1, ARG1 | ALDH1A1 1137/4885KDM4E 3897/4885LMNA 2799/4885 |
| US-20220030862-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | HPD, EBP, TET1 | ALDH1A1 1373/4885KDM4E 567/4885LMNA 384/4885 |
| US-20120316259-A1 | Process For The Co-Encapsulation Of Biocidally Active Compounds In Clay Minerals Functionalized By Nitrogen Compounds | SUV39H1, SUV39H2, TST | ALDH1A1 4167/4885KDM4E 137/4885LMNA 4620/4885 |
| US-11224222-B2 | Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions | ALAD, SCD, DHCR7 | ALDH1A1 92/4885KDM4E 3071/4885LMNA 825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.